Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Daniel Schirmer"'
Autor:
Xiang Zhou, Seungbin Han, Nadine Cebulla, Larissa Haertle, Maximilian J. Steinhardt, Daniel Schirmer, Eva Runau, Leon Flamm, Calvin Terhorst, Laura Jähnel, Cornelia Vogt, Silvia Nerreter, Eva Teufel, Emilia Stanojkovska, Julia Mersi, Umair Munawar, Magnus Schindehütte, Robert Blum, Ann-Kristin Reinhold, Oliver Scherf-Clavel, Heike L. Rittner, Mirko Pham, Leo Rasche, Hermann Einsele, Claudia Sommer, K. Martin Kortüm
Publikováno v:
Biomarker Research, Vol 11, Iss 1, Pp 1-4 (2023)
Abstract We analyzed single nucleotide polymorphisms (SNPs) in PKNOX1 (rs2839629) and in the intergenic region between PKNOX1 and CBS (rs915854) by Sanger sequencing in 88 patients with multiple myeloma treated with bortezomib. All patients (n = 13)
Externí odkaz:
https://doaj.org/article/e043da7190114504a5058138355ee591
Autor:
Nadine Cebulla, Daniel Schirmer, Eva Runau, Leon Flamm, Sonja Gommersbach, Helena Stengel, Xiang Zhou, Hermann Einsele, Ann-Kristin Reinhold, Bruno Rogalla von Bieberstein, Daniel Zeller, Heike Rittner, K. Martin Kortüm, Claudia Sommer
Publikováno v:
Journal of Neurology. 270:2997-3007
Introduction Bortezomib (BTZ) is a selective and reversible proteasome inhibitor and first line treatment for multiple myeloma (MM). One of the side effects is BTZ-induced peripheral neuropathy (BIPN). Until now there is no biomarker which can predic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9cda66cd5a766189ce9064b3d46545d8
https://doi.org/10.1007/s00415-023-11624-2
https://doi.org/10.1007/s00415-023-11624-2